Peripheral metabotropic glutamate receptors as drug targets for pain relief

Volker Neugebauer, Susan M. Carlton

    Research output: Contribution to journalArticle

    58 Citations (Scopus)

    Abstract

    The relatively new family of G-protein-coupled metabotropic glutamate receptors (mGluRs) is comprised of eight cloned subtypes, which are classified into three groups based on their sequence homology, signal transduction mechanisms and receptor pharmacology. It is now well-established that mGluRs in the central nervous system are essential for neuroplasticity associated with normal brain functions but are also critically involved in various neurological and psychiatric disorders. Recent anatomical and behavioural evidence suggests an important role of mGluRs in peripheral tissues in animal models of inflammatory and neuropathic pain. Once the cellular effects of peripheral mGluR activation and inhibition are better understood, certain peripheral mGluR subtypes may become important novel therapeutic targets for the relief of pain associated with peripheral tissue injury. Peripherally acting drugs that modulate nociceptive processing through mGluRs should have the advantage of lacking the central side effects commonly observed with drugs interfering with glutamatergic transmission in the central nervous system.

    Original languageEnglish (US)
    Pages (from-to)349-361
    Number of pages13
    JournalExpert Opinion on Therapeutic Targets
    Volume6
    Issue number3
    DOIs
    StatePublished - 2002

    Fingerprint

    Metabotropic Glutamate Receptors
    Pain
    Neurology
    Pharmaceutical Preparations
    Central Nervous System
    Tissue
    Signal transduction
    Neuronal Plasticity
    Neuralgia
    Sequence Homology
    Nervous System Diseases
    GTP-Binding Proteins
    Psychiatry
    Signal Transduction
    Brain
    Animals
    Animal Models
    Chemical activation
    Pharmacology
    Wounds and Injuries

    Keywords

    • Electrophysiology
    • Inflammation
    • Metabotropic glutamate receptors
    • Neuropathy
    • Nociception
    • Pain
    • Peripheral nervous system
    • Plasticity

    ASJC Scopus subject areas

    • Molecular Medicine
    • Biochemistry, Genetics and Molecular Biology(all)

    Cite this

    Peripheral metabotropic glutamate receptors as drug targets for pain relief. / Neugebauer, Volker; Carlton, Susan M.

    In: Expert Opinion on Therapeutic Targets, Vol. 6, No. 3, 2002, p. 349-361.

    Research output: Contribution to journalArticle

    Neugebauer, Volker ; Carlton, Susan M. / Peripheral metabotropic glutamate receptors as drug targets for pain relief. In: Expert Opinion on Therapeutic Targets. 2002 ; Vol. 6, No. 3. pp. 349-361.
    @article{a7d0e8bafdae4f938aae0d01ffd8ceef,
    title = "Peripheral metabotropic glutamate receptors as drug targets for pain relief",
    abstract = "The relatively new family of G-protein-coupled metabotropic glutamate receptors (mGluRs) is comprised of eight cloned subtypes, which are classified into three groups based on their sequence homology, signal transduction mechanisms and receptor pharmacology. It is now well-established that mGluRs in the central nervous system are essential for neuroplasticity associated with normal brain functions but are also critically involved in various neurological and psychiatric disorders. Recent anatomical and behavioural evidence suggests an important role of mGluRs in peripheral tissues in animal models of inflammatory and neuropathic pain. Once the cellular effects of peripheral mGluR activation and inhibition are better understood, certain peripheral mGluR subtypes may become important novel therapeutic targets for the relief of pain associated with peripheral tissue injury. Peripherally acting drugs that modulate nociceptive processing through mGluRs should have the advantage of lacking the central side effects commonly observed with drugs interfering with glutamatergic transmission in the central nervous system.",
    keywords = "Electrophysiology, Inflammation, Metabotropic glutamate receptors, Neuropathy, Nociception, Pain, Peripheral nervous system, Plasticity",
    author = "Volker Neugebauer and Carlton, {Susan M.}",
    year = "2002",
    doi = "10.1517/14728222.6.3.349",
    language = "English (US)",
    volume = "6",
    pages = "349--361",
    journal = "Expert Opinion on Therapeutic Targets",
    issn = "1472-8222",
    publisher = "Informa Healthcare",
    number = "3",

    }

    TY - JOUR

    T1 - Peripheral metabotropic glutamate receptors as drug targets for pain relief

    AU - Neugebauer, Volker

    AU - Carlton, Susan M.

    PY - 2002

    Y1 - 2002

    N2 - The relatively new family of G-protein-coupled metabotropic glutamate receptors (mGluRs) is comprised of eight cloned subtypes, which are classified into three groups based on their sequence homology, signal transduction mechanisms and receptor pharmacology. It is now well-established that mGluRs in the central nervous system are essential for neuroplasticity associated with normal brain functions but are also critically involved in various neurological and psychiatric disorders. Recent anatomical and behavioural evidence suggests an important role of mGluRs in peripheral tissues in animal models of inflammatory and neuropathic pain. Once the cellular effects of peripheral mGluR activation and inhibition are better understood, certain peripheral mGluR subtypes may become important novel therapeutic targets for the relief of pain associated with peripheral tissue injury. Peripherally acting drugs that modulate nociceptive processing through mGluRs should have the advantage of lacking the central side effects commonly observed with drugs interfering with glutamatergic transmission in the central nervous system.

    AB - The relatively new family of G-protein-coupled metabotropic glutamate receptors (mGluRs) is comprised of eight cloned subtypes, which are classified into three groups based on their sequence homology, signal transduction mechanisms and receptor pharmacology. It is now well-established that mGluRs in the central nervous system are essential for neuroplasticity associated with normal brain functions but are also critically involved in various neurological and psychiatric disorders. Recent anatomical and behavioural evidence suggests an important role of mGluRs in peripheral tissues in animal models of inflammatory and neuropathic pain. Once the cellular effects of peripheral mGluR activation and inhibition are better understood, certain peripheral mGluR subtypes may become important novel therapeutic targets for the relief of pain associated with peripheral tissue injury. Peripherally acting drugs that modulate nociceptive processing through mGluRs should have the advantage of lacking the central side effects commonly observed with drugs interfering with glutamatergic transmission in the central nervous system.

    KW - Electrophysiology

    KW - Inflammation

    KW - Metabotropic glutamate receptors

    KW - Neuropathy

    KW - Nociception

    KW - Pain

    KW - Peripheral nervous system

    KW - Plasticity

    UR - http://www.scopus.com/inward/record.url?scp=0036085243&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0036085243&partnerID=8YFLogxK

    U2 - 10.1517/14728222.6.3.349

    DO - 10.1517/14728222.6.3.349

    M3 - Article

    VL - 6

    SP - 349

    EP - 361

    JO - Expert Opinion on Therapeutic Targets

    JF - Expert Opinion on Therapeutic Targets

    SN - 1472-8222

    IS - 3

    ER -